Mirtazapine improves visual hallucinations in Parkinson's disease: A Case report

29Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Psychotic symptoms often occur as a complication in Parkinson's disease patients, and a set of criteria for Parkinson's disease with psychosis (PDPsy) has been established. Among these criteria, hallucinations are one of the specific symptoms, with visual hallucinations being the most common. While atypical antipsychotic agents are often used for the treatment of PDPsy, adverse effects, including extrapyramidal symptoms, often hinder its continuation or tolerance. There have been some reports and reviews indicating that antidepressants may be effective for PDPsy and other forms of dementia with psychosis. In this report, we present a patient with PDPsy who was treated with one of the new-generation antidepressants, mirtazapine. Mirtazapine improved the patient's refractory psychotic symptoms, especially her visual hallucinations, without worsening her motor symptoms. © 2013 The Authors. Psychogeriatrics © 2013 Japanese Psychogeriatric Society.

Cite

CITATION STYLE

APA

Tagai, K., Nagata, T., Shinagawa, S., Tsuno, N., Ozone, M., & Nakayama, K. (2013). Mirtazapine improves visual hallucinations in Parkinson’s disease: A Case report. Psychogeriatrics, 13(2), 103–107. https://doi.org/10.1111/j.1479-8301.2012.00432.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free